Publications by authors named "Peter Mourik"

Claim this Profile
G
Genome sequence of cluster B1 phages Thunderbird, Gwilliam, and Jiraiya.
Atalie B Bogh, Jacob D Gwilliam, Peter Mourik, Jacob D Scott, Matthew N Jackson

Microbiol Resour Announc· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeatability and reproducibility of the Forskolin-induced swelling (FIS) assay on intestinal organoids from people with Cystic Fibrosis.
Marlou C Bierlaagh, Anabela S Ramalho, Iris A L Silva, Annelotte M Vonk, Rutger M van den Bor, Peter van Mourik

J Cyst Fibros· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Centralized intestinal organoid generation is a feasible and safe approach for personalized medicine as demonstrated in the HIT-CF Europe Organoid Study.
Marlou C Bierlaagh, Peter van Mourik, Annelotte M Vonk, Johanna Pott, Danya Muilwijk

J Cyst Fibros· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A summary of the main themes and findings presented at the ASM Intermountain Branch meeting (2024).
Jay Radke, Javier Ochoa-Repåraz, Jamee Nixon, Sajal Acharya, Haley Bridgewater, Peter Mourik

mSphere· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis.
Kevin W Southern, Carlo Castellani, Elise Lammertyn, Alan Smyth, Donald VanDevanter, Peter van Mourik

J Cyst Fibros· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forskolin-induced organoid swelling is associated with long-term cystic fibrosis disease progression.
Danya Muilwijk, Eyleen de Poel, Peter van Mourik, Sylvia W F Suen, Annelotte M Vonk

Eur Respir J· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Real-World Long-Term Outcomes of People with CF Homozygous for the F508del Mutation Treated with CFTR Modulators.
Danya Muilwijk, Marlou Bierlaagh, Peter van Mourik, Jasmijn Kraaijkamp, Renske van der Meer

J Pers Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lumacaftor/ivacaftor in people with cystic fibrosis with an A455E-CFTR mutation.
Gitte Berkers, Renske van der Meer, Harry Heijerman, Jeffrey M Beekman, Sylvia F Boj, Peter van Mourik

J Cyst Fibros· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Organoid Swelling and Biomarkers of CFTR Function to Determine Effects of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for the F508del Mutation.
Simon Y Graeber, Peter van Mourik, Annelotte M Vonk, Evelien Kruisselbrink, Stephanie Hirtz

Am J Respir Crit Care Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation.
Gitte Berkers, Renske van der Meer, Peter van Mourik, Annelotte M Vonk, Evelien Kruisselbrink

J Cyst Fibros· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R117H-CFTR function and response to VX-770 correlate with mRNA and protein expression in intestinal organoids.
Peter Van Mourik, Paul van Haaren, Evelien Kruisselbrink, Cemil Korkmaz, Hettie M Janssens

J Cyst Fibros· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for Application, Standardization and Validation of the Forskolin-Induced Swelling Assay in Cystic Fibrosis Human Colon Organoids.
Annelotte M Vonk, Peter van Mourik, Anabela S Ramalho, Iris A L Silva, Marvin Statia

STAR Protoc· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank.
Maarten H Geurts, Eyleen de Poel, Gimano D Amatngalim, Rurika Oka, Fleur M Meijers, Peter van Mourik

Cell Stem Cell· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal organoids to model cystic fibrosis.
Peter van Mourik, Jeffrey M Beekman, Cornelis K van der Ent

Eur Respir J· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis.
Gitte Berkers, Peter van Mourik, Annelotte M Vonk, Evelien Kruisselbrink, Johanna F Dekkers

Cell Rep· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentiator synergy in rectal organoids carrying S1251N, G551D, or F508del CFTR mutations.
Johanna F Dekkers, Peter Van Mourik, Annelotte M Vonk, Evelien Kruisselbrink, Gitte Berkers

J Cyst Fibros· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The value to blood establishments of supplier quality audit and of adopting a European Blood Alliance collaborative approach.
Mark J Nightingale, Jan Ceulemans, Stephanie Agoston, Peter van Mourik, Céline Marcou-Cherdel

Blood Transfus· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of the living kidney donor.
Paul Berger, Peter van Mourik, Raechel J Toorop, Franka van Reekum, Arjan van Zuilen

Nephrol Dial Transplant· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis